We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

85 hedge funds and large institutions have $149M invested in Tempest Therapeutics in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

310% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 10

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

16% more funds holding

Funds holding: 73 → 85 (+12)

35% less capital invested

Capital invested by funds: $230M → $149M (-$80.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $208K

Holders
85
Holders Change
+12
Holders Change %
+16.44%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
41
Reduced
10
Closed
6
Calls
–
Puts
$208K
Net Calls
-$208K
Net Calls Change
+$352K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.41M
2
CC
CQS Cayman
Cayman Islands
+$5.35M
3
OAG
Orbis Allan Gray
Bermuda
+$4.27M
4
JHIU
Janus Henderson Investors US
Colorado
+$3.29M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.4M

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$3.06M
2
CAM
Cormorant Asset Management
Massachusetts
-$2.39M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$982K
4
GS
Gagnon Securities
New York
-$254K
5
Northern Trust
Northern Trust
Illinois
-$228K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
26
Sabby Management
Florida
$704K +$1.05M +46 New
BIM
27
BlackRock Investment Management
Delaware
$672K +$343K +15 +52%
HCM
28
Howland Capital Management
Massachusetts
$612K -$114K -5 -11%
TCIM
29
TIAA CREF Investment Management
New York
$495K +$183K +8 +32%
Wells Fargo
30
Wells Fargo
California
$442K +$68.5K +3 +12%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$343K +$137K +6 +35%
Citigroup
32
Citigroup
New York
$323K -$68.5K -3 -13%
Charles Schwab
33
Charles Schwab
California
$321K +$183K +8 +62%
AllianceBernstein
34
AllianceBernstein
Tennessee
$289K +$137K +6 +46%
ERSOT
35
Employees Retirement System of Texas
Texas
$287K – – –
OC
36
Oppenheimer & Co
New York
$271K – – –
AIC
37
AWM Investment Company
New York
$260K – – –
SIP
38
Stoneridge Investment Partners
Pennsylvania
$260K +$206K +9 +113%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$251K +$91.4K +4 +33%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$236K -$982K -43 -74%
Swiss National Bank
41
Swiss National Bank
Switzerland
$232K +$68.5K +3 +25%
TA
42
Teachers Advisors
New York
$232K +$68.5K +3 +25%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$229K +$160K +7 +88%
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$224K +$343K +15 New
NI
45
Numeric Investors
Massachusetts
$220K +$320K +14 New
FMA
46
FNY Managed Accounts
New York
$208K +$320K +14 New
TMC
47
Trellus Management Company
Florida
$208K +$320K +14 New
PPA
48
Parametric Portfolio Associates
Washington
$205K +$22.8K +1 +8%
EA
49
Emerald Acquisition
Washington
$195K +$297K +13 New
ARTA
50
A.R.T. Advisors
New York
$176K +$160K +7 +140%
1
2
3 4

TPST Hedge Fund Activity: Q2 2016 in Review

85 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2016, worth a combined $149M — down 35% from $230M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TPST positions and 6 closed out — a net gain of 12 holders — while 41 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $8.41M. The largest seller was GMT Capital, cutting an estimated $3.06M.

  • 85 institutional investors held Tempest Therapeutics (TPST) as of Q2 2016, up from 73 in Q1 2016.
  • Funds reported $149M of Tempest Therapeutics stock for Q2 2016, down 35% quarter-over-quarter.
  • 18 funds opened new Tempest Therapeutics positions in Q2 2016 and 6 closed out, a net change of +12 holders.
  • The largest Tempest Therapeutics buyer in Q2 2016 was Fidelity Investments, an estimated $8.41M added.
  • The largest Tempest Therapeutics seller in Q2 2016 was GMT Capital, an estimated $3.06M sold.

Based on aggregated 13F filings for Q2 2016.